Claude-Eric Bulabois Selected Research

Claude-Eric Bulabois Research Topics

Disease

10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 12/2012
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 10/2002
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 12/2012
4	Multiple Myeloma 08/2023 - 08/2015
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2007
3	Leukemia 07/2023 - 05/2015
3	Bronchiolitis Obliterans Syndrome 01/2023 - 05/2015
3	Lymphoma (Lymphomas) 11/2021 - 05/2008
2	Hemorrhagic Cystitis 10/2021 - 10/2002
2	Neoplasms (Cancer) 01/2019 - 12/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2008 - 12/2007
1	Thrombotic Microangiopathies 04/2024
1	VEXAS syndrome 02/2024
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021
1	Cystitis 10/2021
1	Hematuria 10/2021
1	Wounds and Injuries (Trauma) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Polymyositis 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Transfusion Reaction 04/2018
1	Hematologic Diseases (Blood Diseases) 04/2018
1	Thrombocytopenia (Thrombopenia) 04/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Sarcoidosis (Schaumann Disease) 09/2016
1	Essential Thrombocythemia 05/2015
1	Residual Neoplasm 03/2013
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 06/2010
1	Pathologic Complete Response 01/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2010
1	Infections 01/2009
1	Toxoplasmosis 01/2009
1	Thrombosis (Thrombus) 10/2008
1	Hemorrhage 10/2008
1	Second Primary Neoplasms (Neoplasms, Second) 12/2007
1	Aspergillosis 10/2005
1	Virus Diseases (Viral Diseases) 10/2002
1	Disease Progression 10/2002

Drug/Important Bio-Agent (IBA)

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2002
3	SteroidsIBA 08/2023 - 01/2019
3	Busulfan (Busulfex)FDA Link 11/2016 - 10/2002
2	fludarabineIBA 11/2016 - 05/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2015 - 05/2014
1	eculizumab FDA Link 04/2024
1	AntigensIBA 07/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	nilotinib FDA Link 01/2023
1	ibrutinibIBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Peroxidase (Myeloperoxidase)IBA 05/2021
1	Decitabine FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	NivolumabIBA 01/2019
1	HLA-DRB3 Chains (HLA DRB3)IBA 05/2018
1	amotosalenIBA 04/2018
1	Hemostatics (Antihemorrhagics)IBA 04/2018
1	SolutionsIBA 04/2018
1	Melphalan (Alkeran)FDA LinkGeneric 01/2018
1	Clofarabine (Clolar)FDA Link 11/2016
1	CalreticulinIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2015
1	Core Binding Factors (Core-Binding Factor)IBA 03/2013
1	Azacitidine (5 Azacytidine)FDA Link 12/2012
1	Immunoglobulin M (IgM)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Fibrinogen (Factor I)FDA Link 10/2008
1	Asparaginase (Elspar)FDA Link 10/2008
1	AntithrombinsIBA 10/2008
1	Cytotoxins (Cytolysins)IBA 12/2007
1	Dihydrotachysterol (AT 10)IBA 12/2007
1	galactomannanIBA 10/2005
1	Factor XIII (Coagulation Factor XIII)IBA 10/2002

Therapy/Procedure

14	Stem Cell Transplantation 01/2023 - 10/2002
9	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2009
9	Therapeutics 08/2023 - 05/2008
7	Transplantation 04/2024 - 12/2007
2	Cell Transplantation 02/2024 - 12/2023
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023 - 05/2014
2	Salvage Therapy 01/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2021
1	Haploidentical Transplantation 01/2019
1	Autologous Transplantation 01/2018
1	Induction Chemotherapy 10/2008
1	Injections 10/2008